| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |